SCHEMBL2686495

SCHEMBL2686495

CCCCCCC(F)Br

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5022714 1.00 MAPT (0.48)
SCHEMBL27629247 1.00 MAPT (0.48)
SCHEMBL9142634 1.00 MAPT (0.48)
SCHEMBL6393139 1.00 MAPT (0.48)
SCHEMBL2686115 0.97
SCHEMBL31119389 0.93 MAPT (0.43)
SCHEMBL5279629 0.88
Phosphine SCHEMBL27809472 0.80 LCK (0.50)
Phosphine SCHEMBL19411902 0.78 DNM1 (0.50)
Phosphine SCHEMBL10882704 0.78 DNM1 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104876791-A Preparation method of 1,1,1,2,2,3,3-heptafluoro-7-bromoheptane SUZHOU JIUWANG ENVIRONMENTAL PROT TECHNOLOGY CO LTD 2015-09-02 CN claimed
EP-0831770-B1 CONTINUOUS FLUOROCHEMICAL MICRODISPERSIONS FOR THE DELIVERY OF PHARMACEUTICAL AGENTS ALLIANCE PHARMA (US) 2000-08-16 EP claimed
US-5874481-A Fluorochemical solutions for the delivery of lipophilic pharmaceutical agents ALLIANCE PHARMACEUTICAL CORP. (US) 1999-02-23 US claimed
CN-1192135-A Continuous fluorochemical microdispersions for delivery of pharmaceutical agents ALLIANCE PHARMA (US) 1998-09-02 CN claimed
EP-0831770-A1 CONTINUOUS FLUOROCHEMICAL MICRODISPERSIONS FOR THE DELIVERY OF PHARMACEUTICAL AGENTS ALLIANCE PHARMACEUTICAL CORP. (US) 1998-04-01 EP claimed
US-5667809-A Continuous fluorochemical microdispersions for the delivery of lipophilic pharmaceutical agents ALLIANCE PHARMACEUTICAL CORP. (US) 1997-09-16 US claimed
WO-1996040053-A1 CONTINUOUS FLUOROCHEMICAL MICRODISPERSIONS FOR THE DELIVERY OF PHARMACEUTICAL AGENTS ALLIANCE PHARMACEUTICAL CORP. (US) 1996-12-19 WO claimed
WO-1996040052-A1 FLUOROCHEMICAL SOLUTIONS FOR THE DELIVERY OF LIPOPHILIC PHARMACEUTICAL AGENTS ALLIANCE PHARMACEUTICAL CORP. (US) 1996-12-19 WO claimed
US-9554993-B2 Pulmonary delivery particles comprising an active agent NOVARTIS AG (CH) 2017-01-31 US disclosed
CN-104876791-A Preparation method of 1,1,1,2,2,3,3-heptafluoro-7-bromoheptane SUZHOU JIUWANG ENVIRONMENTAL PROT TECHNOLOGY CO LTD 2015-09-02 CN disclosed
US-20140234223-A1 NANOEMULSIONS AND USE THEREOF AS CONTRAST AGENTS GUERBET (FR) 2014-08-21 US disclosed
EP-2760480-A1 NANOEMULSIONS AND USE THEREOF AS CONTRAST AGENTS Guerbet (FR) 2014-08-06 EP disclosed
WO-2013045333-A1 NANOEMULSIONS AND USE THEREOF AS CONTRAST AGENTS GUERBET (FR) 2013-04-04 WO disclosed
WO-2013045504-A1 PERFLUORINATED NANOEMULSIONS, METHOD FOR PREPARING SAME, AND USE THEREOF AS A CONTRAST AGENT GUERBET (FR) 2013-04-04 WO disclosed
WO-1998005301-A1 MULTIPLE EMULSIONS COMPRISING A HYDROPHOBIC CONTINUOUS PHASE ALLIANCE PHARMACEUTICAL CORP. (US) 1998-02-12 WO disclosed
US-5667809-A Continuous fluorochemical microdispersions for the delivery of lipophilic pharmaceutical agents ALLIANCE PHARMACEUTICAL CORP. (US) 1997-09-16 US disclosed
WO-1997021425-A1 HYDROCARBON OIL/FLUOROCHEMICAL PREPARATIONS AND METHOD OF USE ALLIANCE PHARMACEUTICAL CORP. (US) 1997-06-19 WO disclosed
WO-1996040053-A1 CONTINUOUS FLUOROCHEMICAL MICRODISPERSIONS FOR THE DELIVERY OF PHARMACEUTICAL AGENTS ALLIANCE PHARMACEUTICAL CORP. (US) 1996-12-19 WO disclosed
WO-1996040052-A1 FLUOROCHEMICAL SOLUTIONS FOR THE DELIVERY OF LIPOPHILIC PHARMACEUTICAL AGENTS ALLIANCE PHARMACEUTICAL CORP. (US) 1996-12-19 WO disclosed
US-5455373-A Method of producing perfluorocarbon halides EXFLUOR RESEARCH CORPORATION (US) 1995-10-03 US disclosed